Pharmaceutical Technology hosts “The Evolution of an NCE’s Suspension Formulation, from pre-GLP Studies to the Pharmacy Shelf” – a webinar presented by Dave Barnes, Ph.D., Vice President of Scientific Affairs for Pace® Life Sciences.
To watch it live, tune in on Thursday, April 14 at 11 AM EDT.
This presentation focuses on the development of suspension formulations of an NCE for oral administration.
Starting with the simple formulations used in safety studies, moving through the multi-dose product used for clinical programs and onto the advanced, long shelf-life product that is commercialized. Both formulation and analytical aspects will be covered.
Suspensions for other routes of administration, e.g., IM or SC injections and eye drops, are outside of the remit of this presentation.